{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:45:35Z","timestamp":1793108735939,"version":"4.5.0"},"reference-count":101,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Am J Sports Med"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Selective androgen receptor modulators (SARMs) are small-molecule compounds that exert agonist and antagonist effects on androgen receptors in a tissue-specific fashion. Because of their performance-enhancing implications, SARMs are increasingly abused by athletes. To date, SARMs have no Food and Drug Administration approved use, and recent case reports associate the use of SARMs with deleterious effects such as drug-induced liver injury, myocarditis, and tendon rupture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>(1) To provide a comprehensive synthesis of the literature pertaining to SARMs from a sports medicine perspective and (2) to provide a better understanding of the clinical effects, treatment protocols, prevalence, and potential contamination associated with athlete-consumed SARMs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Design:<\/jats:title>\n                    <jats:p>Systematic review; Level of evidence, 4.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic review of the English-language literature from PubMed, Cochrane, and Embase databases was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Articles relevant to SARM clinical outcomes, elimination profiles, contamination, safety profiles, prevalence, and doping control were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 72 articles from 2003 to 2022 were identified for inclusion. The prevalence of SARM use among athletes is estimated to be 1% to 3%. SARM preclinical and clinical studies reported significant increases in lean body mass and side effects\u2014including bone remodeling, testosterone suppression, and kidney, liver, and prostate enlargement. Thirteen case reports described 15 cases of SARM abuse. All described patients were men, with a median age of 32 years (range, 19-52 years), more than half were identified as athletes (8\/15), and all ingested SARMs orally for a mean course of 8 weeks. Five patients described in the case reports explicitly denied \u201cillicit drug use,\u201d implying patients may believe their use to be legal. Athletes most commonly purchased SARMs online, and most of these compounds have been shown to be contaminated with other substances, contributing to adverse effects. Athletes reported consuming SARMs at much higher doses than clinically studied, which may increase the risk of the reported side effects, such as liver injury, impaired insulin sensitivity, cardiovascular events, and tendon damage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The results of this systematic review serve to educate sports medicine clinicians and researchers on how to better identify, diagnose, and treat athlete SARM abuse. SARM use is associated with increased muscle mass, hepatotoxicity, cardiotoxicity, tendon damage, and androgenic side effects throughout the body\u2014including prostate enlargement and serum testosterone suppression. Identifying and treating SARM abuse requires taking a thorough substance and supplement use history with open communication, providing literature-supported patient education, negotiating SARM discontinuation, and performing multidisciplinary treatment of adverse events. Athlete SARM abuse is increasingly widespread and unsafe, and public health oversight bodies should advocate for regulation of these gray-market compounds.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/03635465241252435","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T04:02:13Z","timestamp":1736049733000},"page":"999-1009","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":15,"title":["Athlete Selective Androgen Receptor Modulators Abuse: A Systematic Review"],"prefix":"10.1177","volume":"53","author":[{"given":"Nikhil","family":"Vasireddi","sequence":"first","affiliation":[{"name":"Case Western Reserve University School of Medicine, Cleveland, Ohio, USA"},{"name":"University Hospitals Drusinsky Sports Medicine Institute, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik A.","family":"Hahamyan","sequence":"additional","affiliation":[{"name":"East Tennessee State University, Quillen College of Medicine, Johnson City, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heath P.","family":"Gould","sequence":"additional","affiliation":[{"name":"Hospital for Special Surgery, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.M.","family":"Gregory","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth B.","family":"Gausden","sequence":"additional","affiliation":[{"name":"Hospital for Special Surgery, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Dodson","sequence":"additional","affiliation":[{"name":"Rothman Institute, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Voos","sequence":"additional","affiliation":[{"name":"Case Western Reserve University School of Medicine, Cleveland, Ohio, USA"},{"name":"University Hospitals Drusinsky Sports Medicine Institute, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob G.","family":"Calcei","sequence":"additional","affiliation":[{"name":"Case Western Reserve University School of Medicine, Cleveland, Ohio, USA"},{"name":"University Hospitals Drusinsky Sports Medicine Institute, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,1,5]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-3991(02)00124-6"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000000409"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000000370"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/gls078"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000000518"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e32832a3d79"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1113\/EP090741"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2019.11.02"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-011-0034-6"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.3001"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70055-X"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2015-1479"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/and.14238"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41443-021-00465-0"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2021.787954"},{"key":"e_1_3_4_17_2","unstructured":"Epstein J. Three Clemson players fail drug test ahead of College Football Playoff game in Cotton Bowl. USA Today. December 24 2018. https:\/\/www.usatoday.com\/story\/sports\/ncaaf\/2018\/12\/24\/clemson-players-fail-drug-test-ostarine-before-college-football-playoff\/2409250002\/"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1456"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2020.100926"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-0627"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0572"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2021.123048"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101598"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2016.09.015"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.CC.20.00635"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2011.07.014"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.372"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/00913847.2022.2078679"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu15153330"},{"key":"e_1_3_4_30_2","unstructured":"Harrison D. Canoe star Laurence Vincent Lapointe found not guilty of taking banned substance | CBC Sports. CBC.ca. Published January 27 2020. https:\/\/www.cbc.ca\/sports\/olympics\/summer\/canoe-kayak\/laurence-vincent-lapointe-doping-verdict-1.5441395"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1039\/D2TB00270A"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40798-021-00371-1"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-018-0929-9"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2034518"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000001370"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-009-9962-7"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-006-9152-9"},{"issue":"2","key":"e_1_3_4_38_2","article-title":"Selective androgen receptor modulator induced hepatotoxicity","volume":"14","author":"Khan S","year":"2022","unstructured":"Khan S, Fackler J, Gilani A, Murphy S, Polintan L. Selective androgen receptor modulator induced hepatotoxicity. Cureus. 2022;14(2):e22239.","journal-title":"Cureus"},{"issue":"1","key":"e_1_3_4_39_2","first-page":"56","article-title":"LGD-4033, S-4 and MK-2866\u2013testing for SARMs in hair: about 2 doping cases","volume":"31","author":"Kintz P","year":"2019","unstructured":"Kintz P, Ameline A, Gheddar L, Raul JS. LGD-4033, S-4 and MK-2866\u2013testing for SARMs in hair: about 2 doping cases. Ann\u2009Toxicol\u2009Anal. 2019;31(1):56-63.","journal-title":"Ann\u2009Toxicol\u2009Anal"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2902"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.3390\/toxics9100251"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i16.4062"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01865-9"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-019-00613-1"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-020-00751-x"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1743-5"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2908"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084404"},{"issue":"4","key":"e_1_3_4_49_2","article-title":"Effect of ostarine (enobosarm\/GTX024), a selective androgen receptor modulator, on adipocyte metabolism in Wistar rats","volume":"70","author":"Leciejewska N","year":"2019","unstructured":"Leciejewska N, Pruszynska-Oszmalek E, Bien J, Nogowski L, Kolodziejski PA. Effect of ostarine (enobosarm\/GTX024), a selective androgen receptor modulator, on adipocyte metabolism in Wistar rats. J Physiol Pharmacol. 2019;70(4):10.26402\/jpp.2019.4.04.","journal-title":"J Physiol Pharmacol"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usac039"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2021.08.003"},{"key":"e_1_3_4_52_2","unstructured":"Mahoney B. Suspended Joakim Noah says using supplement to aid injuries \u201cbackfired.\u201d NBA.com. Published March 28 2017. https:\/\/www.nba.com\/news\/joakim-noah-suspension-supplement-backfired"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu9101093"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1021\/ml1002508"},{"issue":"1","key":"e_1_3_4_55_2","first-page":"188","article-title":"Selective androgen receptor modulators: an emerging liver toxin","volume":"11","author":"Mohideen H","year":"2023","unstructured":"Mohideen H, Hussain H, Dahiya DS, Wehbe H. Selective androgen receptor modulators: an emerging liver toxin. J Clin Transl Hepatol. 2023;11(1):188-196.","journal-title":"J Clin Transl Hepatol"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2017.06.013"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1210\/me.2008-0160"},{"key":"e_1_3_4_58_2","unstructured":"Norlander M. Allonzo Trier ruled ineligible due to banned substance; Arizona plans to appeal. CBSSports.com. Published February 22 2018. https:\/\/www.cbssports.com\/college-basketball\/news\/allonzo-trier-ruled-ineligible-due-to-banned-substance-arizona-plans-to-appeal\/"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2020.1770277"},{"issue":"1","key":"e_1_3_4_60_2","article-title":"Acute myocarditis from the use of selective androgen receptor modulator (SARM) RAD-140 (Testolone)","volume":"14","author":"Padappayil RP","year":"2022","unstructured":"Padappayil RP, Chandini Arjun A, Vivar Acosta J, Ghali W, Mughal MS. Acute myocarditis from the use of selective androgen receptor modulator (SARM) RAD-140 (Testolone). Cureus. 2022;14(1):e21663.","journal-title":"Cureus"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.3345"},{"key":"e_1_3_4_62_2","unstructured":"Patra K. Cardinals WR DeAndre Hopkins still hopes to reduce six-game suspension. NFL.com. Published June 23 2022. https:\/\/www.nfl.com\/news\/cardinals-wr-deandre-hopkins-still-hopes-to-reduce-six-game-suspension"},{"key":"e_1_3_4_63_2","unstructured":"Patra K. Titans OL Taylor Lewan officially suspended 4 games. NFL.com. Published August 23 2019. https:\/\/www.nfl.com\/news\/titans-ol-taylor-lewan-officially-suspended-4-games-0ap3000001043763"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25751"},{"key":"e_1_3_4_65_2","unstructured":"Reuters. GB stripped of Olympic silver after Ujah positive. ESPN.com. Published February 18 2022. https:\/\/www.espn.com\/olympics\/story\/_\/id\/33321343\/cj-ujah-positive-test-sees-team-gb-stripped-olympic-silver-medal"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.556581"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01794-7"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540390074039"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2917"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sxmr.2018.09.006"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.2337\/cd21-0044"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113849"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1466"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2014.302348"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4700"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.91"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.283"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2017.01.040"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-011-5655-2"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2019.08.008"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2018.03.043"},{"key":"e_1_3_4_82_2","unstructured":"USADA. Supplement warning: athletes at risk from ostarine in supplements. Published July 25 2017. http:\/\/www.usada.org\/athlete-advisory\/growing-evidence-ostarine-athlete-risk"},{"key":"e_1_3_4_83_2","unstructured":"USADA. U.S. track & field athlete Gil Roberts accepts doping sanction. Published December 8 2022. https:\/\/www.usada.org\/sanction\/gil-roberts-accepts-doping-sanction\/"},{"key":"e_1_3_4_84_2","unstructured":"USADA. USADA resolves four cases involving ostarine under the UFC anti-doping policy. Published April 26 2019. https:\/\/www.lawinsport.com\/topics\/news\/item\/usada-resolves-four-cases-involving-ostarine-following-positive-tests-under-the-ufc-anti-doping-policy"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17069"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1080\/00913847.2022.2108352"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2019.04.050"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.3390\/jox13020017"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2017.0029"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12070666"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-021-03740-7"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2933"},{"key":"e_1_3_4_93_2","doi-asserted-by":"publisher","DOI":"10.3390\/foods9081012"},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2015.10.001"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.14740\/jmc3937"},{"key":"e_1_3_4_96_2","unstructured":"World Anti-Doping Agency. 2016 Anti-Doping Testing Figures. World Anti-Doping Agency [WADA]. Published 2017. https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2016_anti-doping_testing_figures.pdf"},{"key":"e_1_3_4_97_2","unstructured":"World Anti-Doping Agency. 2017 Anti-Doping Testing Figures. World Anti-Doping Agency [WADA]. Published 2018. https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2017_anti-doping_testing_figures_en_0.pdf"},{"key":"e_1_3_4_98_2","unstructured":"World Anti-Doping Agency. 2018 Anti-Doping Testing Figures. World Anti-Doping Agency [WADA]. Published 2019. https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2018_testing_figures_report.pdf"},{"key":"e_1_3_4_99_2","unstructured":"World Anti-Doping Agency. 2019 Anti-Doping Testing Figures. World Anti-Doping Agency [WADA]. Published 2020. https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2019_anti-doping_testing_figures_en.pdf"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.040840"},{"key":"e_1_3_4_101_2","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13583"},{"key":"e_1_3_4_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2019.02.014"}],"container-title":["The American Journal of Sports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03635465241252435","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03635465241252435","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03635465241252435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:38:16Z","timestamp":1779266296000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03635465241252435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,5]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1177\/03635465241252435"],"URL":"https:\/\/doi.org\/10.1177\/03635465241252435","relation":{},"ISSN":["0363-5465","1552-3365"],"issn-type":[{"value":"0363-5465","type":"print"},{"value":"1552-3365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,5]]}}}